GE ups digital mammo capabilities with purchase of Image Diagnost International
The new IT systems from Image Diagnost for diagnosing breast cancer will be available for GE's Senographe Essential. Source: GE Healthcare  
GE Healthcare today announced it has acquired Image Diagnost International, a provider of IT systems used for diagnosing breast cancer. GE did not disclose the terms of the transaction.

Image Diagnost develops integrated software solutions for mammography workflow and image processing, which will expand GE Healthcare’s capabilities in breast cancer detection, offering clinicians and national screening services, according to David Caumartin, general manager of GE’s mammography business.
“Image Diagnost and GE Healthcare have a shared vision on how best to accelerate the adoption of digital mammography and to harness the benefits that the new technology brings to the diagnosis and detection of breast cancer,” said Caumartin.
GE Healthcare plans to develop the Image Diagnost facility in Munich, Germany, into a center of excellence in breast cancer detection software.

 “The additional resources that GE Healthcare brings will allow us to accelerate our development programs and bring our products to a much wider customer base.  The combination of the two companies will bring substantial benefits to hospitals, screening services and women’s healthcare worldwide,” Wilfried Schneider, PhD, founder of Image Diagnost.
Image Diagnost, founded in 2005, has more than 150 installations of its software suites and has filed for U.S. FDA approval for its Image Diagnost MammoWorkstation.

For more information on Image Diagnost and its products, visit: